To further validate the oncogenic effect of BRD1 in vivo, we conducted experiments that demonstrated a significant reduction in tumor volumes and weights upon BRD1 knockdown, indicating effective tumor regression (Fig. 1P–R). Here, BRD1 is linked to neoplasm.